Revenue
0 USD
2025 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Annual consolidated revenue for 2024: about USD 16.89M, using the latest reported figures. The previous period, 2023, was about USD 16.3M.
0 USD
2025 Q3 · USD
-5.5 million USD
2025 Q3 · USD
-5.5 million USD
2025 Q3 · USD
23880142 USD
17050320 shares
16.38% · 2.4 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-10.
Financial data available through: 2024-09-30.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 16.3 million
–
Current period
USD 16.89 million
–
16886419 − 16296958 = 589461 USD
16296958 USD · 2022-10-01 – 2023-09-30
Inspect prior input Prior source16886419 USD · 2023-10-01 – 2024-09-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 93.15 million
–
Current period
−USD 37.8 million
–
-37801426 − -93152692 = 55351266 USD
-93152692 USD · 2022-10-01 – 2023-09-30
Inspect prior input Prior source-37801426 USD · 2023-10-01 – 2024-09-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 88.01 million
–
Current period
−USD 21.7 million
–
-21700000 − -88013814 = 66313814 USD
-88013814 USD · 2022-10-01 – 2023-09-30
Inspect prior input Prior source-21700000 USD · 2023-10-01 – 2024-09-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 665,700
–
Current period
USD 158,322
–
158322 − 665700 = -507378 USD
665700 USD · 2022-10-01 – 2023-09-30
Inspect prior input Prior source158322 USD · 2023-10-01 – 2024-09-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2022-10-01 – 2023-09-30 | 16296958 | 110079174 Derived | -93782216 | -629524 Derived | -93152692 | -88679514 Derived | Source
|
| 2024 2023-10-01 – 2024-09-30 | 16886419 | 53055479 Derived | -36169060 | 1632366 Derived | -37801426 | -21858322 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 16296958 |
|
| 2024 | Revenue | 16886419 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | 3.6% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | -575.5% |
|
| 2024 | Operating margin | -214.2% |
|
| 2023 | Net margin | -571.6% |
|
| 2024 | Net margin | -223.9% |
|
| 2023 | Free cash flow margin | -544.1% |
|
| 2024 | Free cash flow margin | -129.4% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -88013814 |
|
| 2024 | Operating cash flow | -21700000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | -88679514 |
|
| 2024 | Free cash flow | -21858322 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Liabilities / assets | 60.7% |
|
| 2024 | Liabilities / assets | 46.5% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Current assets / current liabilities | 1.29× |
|
| 2024 | Current assets / current liabilities | 2.97× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2022-10-01 – 2023-09-30 | −USD 93.15 million Exact valueExact value: -93152692 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 88.01 million Exact valueExact value: -88013814 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 665,700 Exact valueExact value: 665700 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 88.68 million Calculation and evidence-88013814 − 665700 USD Exact free cash flow: -88679514 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-10-01 – 2024-09-30 | −USD 37.8 million Exact valueExact value: -37801426 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21.7 million Exact valueExact value: -21700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 158,322 Exact valueExact value: 158322 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21.86 million Calculation and evidence-21700000 − 158322 USD Exact free cash flow: -21858322 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
177 filings · 6,328 latest values · 6,328 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000863894, 863894, VERU, edgar:863894, veru
Also known as FEMALE HEALTH CO, VERU INC., Veru Inc.